| 30/05/24 | 07:00:11 | 30 May 2024 | | 2023 Annual Results |
| 24/05/24 | 07:00:09 | 24 May 2024 | | New data to be presented at ATC |
| 27/02/24 | 16:08:57 | 27 Feb 2024 | | Holding(s) in Company |
| 22/02/24 | 07:00:09 | 22 Feb 2024 | | Holding(s) in Company |
| 21/02/24 | 16:53:07 | 21 Feb 2024 | | Holding(s) in Company |
| 21/02/24 | 07:00:06 | 21 Feb 2024 | | Holding(s) in Company |
| 19/02/24 | 12:35:02 | 19 Feb 2024 | | Result of General Meeting |
| 14/02/24 | 07:00:04 | 14 Feb 2024 | | Result of Retail Offer |
| 31/01/24 | 07:00:11 | 31 Jan 2024 | | Verici Dx announces new research initiative |
| 26/01/24 | 12:32:07 | 26 Jan 2024 | | Publication of Circular |
| 25/01/24 | 11:00:00 | 25 Jan 2024 | | Launch of Retail Offer |
| 24/01/24 | 18:11:04 | 24 Jan 2024 | | Result of Placing |
| 24/01/24 | 10:39:41 | 24 Jan 2024 | | Close of Accelerated Bookbuild |
| 24/01/24 | 07:00:07 | 24 Jan 2024 | | Proposed Fundraising |
| 08/01/24 | 07:00:04 | 8 Jan 2024 | | CAP accreditation |
| 08/01/24 | 07:00:04 | 8 Jan 2024 | | Medicare National Payment Rate Confirmation |
| 11/12/23 | 07:00:09 | 11 Dec 2023 | | Tutivia™ validation study published in Journal |
| 29/11/23 | 07:00:17 | 29 Nov 2023 | | ISO 27001 Information Security Certification |
| 20/11/23 | 07:00:06 | 20 Nov 2023 | | Investor Presentation |
| 15/11/23 | 07:00:11 | 15 Nov 2023 | | Commercialisation agreement with Thermo Fisher |
| 02/11/23 | 07:00:13 | 2 Nov 2023 | | Clarava™ poster to be presented at ASN Kidney Week |
| 29/09/23 | 07:00:14 | 29 Sept 2023 | | Half-year Report |
| 20/07/23 | 07:00:10 | 20 Jul 2023 | | CLIA Certificate of Compliance update |
| 06/07/23 | 07:00:08 | 6 Jul 2023 | | Investor Presentation |
| 03/07/23 | 07:00:05 | 3 Jul 2023 | | Successful clinical validation of Clarava™ |
| 29/06/23 | 16:57:41 | 29 Jun 2023 | | Result of AGM |
| 06/06/23 | 07:00:08 | 6 Jun 2023 | | Notice of AGM and posting of Annual Report |
| 05/06/23 | 07:01:02 | 5 Jun 2023 | | 2022 Annual Results |
| 05/06/23 | 07:00:06 | 5 Jun 2023 | | Proposed US pricing for Tutivia™ |
| 31/05/23 | 07:00:07 | 31 May 2023 | | Notice of Results |
| 24/05/23 | 07:01:02 | 24 May 2023 | | Update re. EKF distribution of shares in Verici Dx |
| 24/05/23 | 07:00:12 | 24 May 2023 | | Distribution of shares in Verici Dx plc |
| 24/04/23 | 07:00:09 | 24 Apr 2023 | | Final results timing |
| 28/03/23 | 11:05:40 | 28 Mar 2023 | | Second Price Monitoring Extn |
| 28/03/23 | 11:00:31 | 28 Mar 2023 | | Price Monitoring Extension |
| 28/03/23 | 09:05:35 | 28 Mar 2023 | | Second Price Monitoring Extn |
| 28/03/23 | 09:00:21 | 28 Mar 2023 | | Price Monitoring Extension |
| 27/03/23 | 16:35:13 | 27 Mar 2023 | | Price Monitoring Extension |
| 27/03/23 | 11:05:45 | 27 Mar 2023 | | Second Price Monitoring Extn |
| 27/03/23 | 11:00:29 | 27 Mar 2023 | | Price Monitoring Extension |
| 22/03/23 | 07:00:04 | 22 Mar 2023 | | Operational Update |
| 21/03/23 | 16:40:29 | 21 Mar 2023 | | Second Price Monitoring Extn |
| 21/03/23 | 16:35:16 | 21 Mar 2023 | | Price Monitoring Extension |
| 13/03/23 | 07:00:07 | 13 Mar 2023 | | Statement re. Silicon Valley Bank |
| 09/03/23 | 07:00:06 | 9 Mar 2023 | | Two key patents granted in the US |
| 02/03/23 | 07:00:06 | 2 Mar 2023 | | CLIA Certificate of Compliance |
| 27/02/23 | 14:00:10 | 27 Feb 2023 | | Price Monitoring Extension |
| 07/12/22 | 07:00:07 | 7 Dec 2022 | | Director/PDMR Shareholding |
| 01/12/22 | 18:07:55 | 1 Dec 2022 | | Correction: Holding(s) in Company |
| 03/10/22 | 07:00:14 | 3 Oct 2022 | | Product rebranding as Tutivia™ |
